Late Onset and Protracted Course of Steroid Refractory Chronic Graft-Versus-Host Disease

Case Reports in Hematology
doi 10.1155/2015/692175
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Tocilizumab for Steroid Refractory Acute Graft-Versus-Host Disease

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2015English

Combination of Bortezomib Plus Ruxolitinib in Steroid-Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2018English

Rituximab Provides Steroid-Sparing Therapy in New-Onset Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Sirolimus for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2009English

Imatinib Mesylate for the Treatment of Steroid-Refractory Sclerotic-Type Cutaneous Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Outcomes of Infliximab in Management of Steroid-Refractory Acute Graft Versus Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-Versus-Host Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Response to Thalidomide Therapy in Refractory Chronic Graft-Versus-Host Disease

Bone Marrow Transplantation
TransplantationHematology
2000English

Etanercept as Treatment of Steroid-Refractory Acute Graft Versus Host Disease in Pediatric Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy